FDA Releases Guidance for Human Blood and Blood Components Submission

Summary

The Food and Drug Administration (FDA) has made available a document to help companies prepare and submit applications for human blood and blood components intended for transfusion or further manufacture, as part of its efforts to streamline the regulatory process and protect public health.